The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Up 216.2% in January

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) saw a large growth in short interest in January. As of January 15th, there was short interest totalling 23,400 shares, a growth of 216.2% from the December 31st total of 7,400 shares. Based on an average daily trading volume, of 28,300 shares, the days-to-cover ratio is presently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Shares of NASDAQ CGABL opened at $18.85 on Wednesday. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 52 week low of $17.48 and a 52 week high of $20.85. The business has a 50-day simple moving average of $18.56 and a two-hundred day simple moving average of $19.16.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Saturday, February 15th. Stockholders of record on Saturday, February 1st will be given a dividend of $0.2891 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 6.13%. The ex-dividend date of this dividend is Friday, January 31st. This is an increase from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.